Title: Dalbavancin (BI-387) for the treatment of complicated skin and skin structure infection.
Journal: Expert review of anti-infective therapy 20150201
Title: [In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci].
Journal: Mikrobiyoloji bulteni 20120701
Title: A carrier protein strategy yields the structure of dalbavancin.
Journal: Journal of the American Chemical Society 20120314
Title: MRSA new treatments on the horizon: current status.
Journal: Injury 20111201
Title: Susceptibility of molecularly characterized hospital-associated methicillin-resistant Staphylococcus aureus isolates to dalbavancin.
Journal: Journal of chemotherapy (Florence, Italy) 20111001
Title: Dalbavancin: Quantification in human plasma and urine by a new improved high performance liquid chromatography-tandem mass spectrometry method.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110901
Title: In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
Journal: Diagnostic microbiology and infectious disease 20110301
Title: Outpatient parenteral antimicrobial therapy: Recent developments and future prospects.
Journal: Current opinion in investigational drugs (London, England : 2000) 20100801
Title: Evaluation of dalbavancin as chiral selector for HPLC and comparison with teicoplanin-based chiral stationary phases.
Journal: Chirality 20100515
Title: New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.
Journal: Drugs 20100507
Title: [Update on antimicrobial chemotherapy].
Journal: Medecine et maladies infectieuses 20100301
Title: A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.
Journal: Pharmacotherapy 20100101
Title: Modeled dalbavancin transmembrane clearance during intermittent and continuous renal replacement therapies.
Journal: Blood purification 20100101
Title: In vitro activity of dalbavancin against staphylococci isolated in Istanbul, Turkey.
Journal: Chemotherapy 20100101
Title: Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
Journal: Infectious disease clinics of North America 20091201
Title: New antimicrobial agents for methicillin-resistant Staphylococcus aureus.
Journal: Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 20091201
Title: Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria.
Journal: The Journal of infection 20090901
Title: Antimicrobial development in the era of emerging resistance.
Journal: Mini reviews in medicinal chemistry 20090701
Title: Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
Journal: Diagnostic microbiology and infectious disease 20090601
Title: Pharmacokinetics of dalbavancin in patients with renal or hepatic impairment.
Journal: Journal of clinical pharmacology 20090401
Title: A single-dose combination therapy that both prevents and treats anthrax infection.
Journal: Vaccine 20090313
Title: New antibiotics for healthcare-associated pneumonia.
Journal: Seminars in respiratory and critical care medicine 20090201
Title: In vitro activity of dalbavancin against enterococci isolates from wild animals, pets, poultry and humans in Portugal.
Journal: Journal of basic microbiology 20081201
Title: Antimicrobial agents in treatment of MRSA infections.
Journal: Disease-a-month : DM 20081201
Title: Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibiotic.
Journal: Journal of clinical pharmacology 20080901
Title: Dalbavancin: a lipoglycopeptide antibacterial for Gram-positive infections.
Journal: Expert opinion on pharmacotherapy 20080701
Title: Dalbavancin: a new lipoglycopeptide antibiotic.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080401
Title: Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080215
Title: Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.
Journal: Expert review of anti-infective therapy 20080201
Title: Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.
Journal: Pakistan journal of pharmaceutical sciences 20080101
Title: Dalbavancin.
Journal: Drugs 20080101
Title: Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
Journal: Expert review of anti-infective therapy 20071201
Title: Pharmacokinetics of dalbavancin in plasma and skin blister fluid.
Journal: The Journal of antimicrobial chemotherapy 20070901
Title: Dalbavancin, a long-acting lipoglycopeptide for the treatment of multidrug-resistant Gram-positive bacteria.
Journal: Expert review of anti-infective therapy 20070801
Title: Dalbavancin: a novel antimicrobial.
Journal: International journal of clinical practice 20070501
Title: Review of dalbavancin, a novel semisynthetic lipoglycopeptide.
Journal: Expert opinion on investigational drugs 20070501
Title: Dalbavancin: a review.
Journal: Drugs of today (Barcelona, Spain : 1998) 20070501
Title: Biotransformations of lipoglycopeptides to obtain novel antibiotics.
Journal: The Journal of antibiotics 20070401
Title: [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Journal: Recenti progressi in medicina 20070301
Title: Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system.
Journal: The Journal of antimicrobial chemotherapy 20061001
Title: Effect of dalbavancin on the normal intestinal microflora.
Journal: The Journal of antimicrobial chemotherapy 20060901
Title: Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy.
Journal: Current opinion in investigational drugs (London, England : 2000) 20060801
Title: Understanding and manipulating glycopeptide pathways: the example of the dalbavancin precursor A40926.
Journal: Journal of industrial microbiology & biotechnology 20060701
Title: Dalbavancin: a novel lipoglycopeptide antibacterial.
Journal: Pharmacotherapy 20060701
Title: Evaluation of dalbavancin in combination with nine antimicrobial agents to detect enhanced or antagonistic interactions.
Journal: International journal of antimicrobial agents 20060601
Title: Antibacterial drug discovery and development--SRI's 11th Annual Summit. Antibacterial trends and current research.
Journal: IDrugs : the investigational drugs journal 20060601
Title: Dalbavancin: a review for dermatologists.
Journal: Dermatology online journal 20060530
Title: Dalbavancin: a new option for the treatment of gram-positive infections.
Journal: The Annals of pharmacotherapy 20060301
Title: Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).
Journal: Diagnostic microbiology and infectious disease 20060201
Title: Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections.
Journal: Diagnostic microbiology and infectious disease 20060201
Title: Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
Journal: Diagnostic microbiology and infectious disease 20051201
Title: Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol.
Journal: Journal of chemotherapy (Florence, Italy) 20051201
Title: Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051115
Title: Population pharmacokinetic analysis of dalbavancin, a novel lipoglycopeptide.
Journal: Journal of clinical pharmacology 20051101
Title: New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
Journal: Current opinion in critical care 20051001
Title: Acquisitions not a cure for anti-infectives.
Journal: Nature reviews. Drug discovery 20050901
Title: Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo.
Journal: The Journal of infection 20050401
Title: Origin, structure, and activity in vitro and in vivo of dalbavancin.
Journal: The Journal of antimicrobial chemotherapy 20050301
Title: In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide.
Journal: The Journal of antimicrobial chemotherapy 20050301
Title: Human pharmacokinetics and rationale for once-weekly dosing of dalbavancin, a semi-synthetic glycopeptide.
Journal: The Journal of antimicrobial chemotherapy 20050301
Title: Pharmacokinetics and excretion of dalbavancin in the rat.
Journal: The Journal of antimicrobial chemotherapy 20050301
Title: Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050201
Title: Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050201
Title: Dalbavancin: an investigational glycopeptide.
Journal: Expert review of anti-infective therapy 20041201
Title: Recent advances in the treatment of infections due to resistant Staphylococcus aureus.
Journal: Current opinion in infectious diseases 20041201
Title: Glycopeptides in clinical development: pharmacological profile and clinical perspectives.
Journal: Current opinion in pharmacology 20041001
Title: Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods.
Journal: The Journal of antimicrobial chemotherapy 20040901
Title: Current and new antimicrobial agents.
Journal: American heart journal 20040401
Title: Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates.
Journal: Diagnostic microbiology and infectious disease 20040201
Title: Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptide.
Journal: International journal of antimicrobial agents 20040201
Title: Glycopeptide antibiotics: from conventional molecules to new derivatives.
Journal: Drugs 20040101
Title: Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031115
Title: The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by nonomuraea species.
Journal: Chemistry & biology 20030601
Title: Audiologic monitoring for potential ototoxicity in a phase I clinical trial of a new glycopeptide antibiotic.
Journal: Journal of the American Academy of Audiology 20030401
Title: Dalbavancin (Biosearch Italia/Versicor).
Journal: Current opinion in investigational drugs (London, England : 2000) 20020201
Title: Heine HS, et al. Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model. Antimicrob Agents Chemother. 2010 Mar;54(3):991-6.
Title: Bennett JW, et al. Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review. Ther Clin Risk Manag. 2008 Feb;4(1):31-40.
